Indegene Limited IPO is a MAIN BOARD IPO. They are going to raise ₹1,841.76 Crores via IPO. The issue is priced at ₹430 to ₹452 per equity share. The IPO is to be listed on NSE, BSE
Indegene Limited IPO opens for subscription on May 06, 2024. and closes on May 08, 2024. The allotment for the Indegene Limited IPO is expected to be finalized on May 09, 2024. Indegene Limited IPO will list on BSE, NSE with tentative listing date fixed as 13 May 2024.
| IPO Details | Allotment |
| Minimum Investment ₹14,916 / 1– Lot (33 shares) | Price Range ₹430-₹452 | |
| Max Quantity 13-Lots/ (429 Shares) | Max Investment ₹193,908 | Retail Discount ₹0 |
| Investor category and sub category Individual- HNI & Retail | Issue Size 1,841.76 Cr | Employee Discount ₹30 |
| Total Issue Size 40,746,891 Shares (Aggregating up to ₹1,841.76 Cr) | Share Holding Pree Issue 22,435,091 | Issue Type Book build Issue IPO |
| Fresh Issue Share 16,814,159 Shares (Aggregating up to ₹760.00 Cr) | Share Holding Post Issue 239,249,250 | Listing At BSE, NSE |
| Offer For Sale 23,932,732 Shares of ₹2 (Aggregating up to ₹1,081.76 Cr) | Face value ₹2 |
IPO Dates
| Offer Starts | 06 May 2024 |
| Offer Ends | 08 May 2024 |
| Allotment | 09 May 2024 |
| Refunds | 10 May 2024 |
| Credit of shares to Demat account | 10 May 2024 |
| IPO Listing | 13 May 2024 |
About Indegene Limited
Founded in 1998, Indegene Limited provides digital services for the life sciences industry. They assist with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaints management, and sales/marketing support.
The company’s services can be divided into following categories
Enterprise Commercial Solutions
Omnichannel Activation
Enterprise Medical Solutions
Enterprise Clinical Solutions and consultancy services
The subsidiary of the company, DT Associates Limited, provides consulting services under the “DT Consulting” brand. It helps life sciences companies manage their digital transformation efforts to ensure continued success in customer experience.
The company received the Platinum Level award at the 2023 Healthy Workplace Conference and Awards, a recognition given by Arogya World India Trust in partnership with the Public Health Foundation of India.
| Founded in | Managing Director |
| 1998 |
Indegene Limited IPO Prospectus
| . | |
| DRHP Draft Prospectus | Click Here |
| RHP Draft Prospectus | Click Here |
Indegene Limited IPO Lot Size
Indegene Limited IPO minimum market lot is 33 shares with ₹14,916 application amount. The retail investors can apply up-to 13 lots with 429 shares or ₹193,908 amount.
| Application | Lots | Shares | Amount |
| Retail (Min) | 1 | 36 | ₹14,916 |
| Retail (Max) | 13 | 429 | ₹193,908 |
| S-HNI (Min) | 14 | 462 | ₹208,824 |
| S-HNI (Max) | 67 | 2,211 | ₹999,372 |
| B-HNI (Min) | 68 | 2,244 | ₹1,014,288 |
Share Holding
BCP Topco VII Pte. Ltd. is the promoter of the Company.
| Share Holding Pre-Issue | 30.71% |
| Share Holding Post-Issue |
Financials
| Year | 2023 | 2022 | 2021 |
| Revenue | ₹2,364.10 | ₹1,690.50 | ₹996.92 |
| Assets | ₹2,203.87 | ₹1,353.47 | ₹596.04 |
| Profit | ₹266.10 | ₹162.82 | ₹149.41 |
| All values are in Rs. Cr |
Fundamentals
| Values | Values | ||
| Market cap | 10814.07Cr | ROE | % |
| P/E (X) | 37.78 | ROCE | % |
| POST P/E (X) | 33.53 | EPS | 11.96 |
| Debt to Equity | 0.3 | RONW | 18.23% |
Objects of the Issue
- Repayment/prepayment of indebtedness of one of our Material Subsidiaries, ILSL Holdings, Inc
- Funding the capital expenditure requirements of our Company and one of our Material Subsidiaries, Indegene Inc
- General corporate purposes and inorganic growth.
Brokerage Firm IPO Review
- To be updated soon
| Indegene Limited Contact Details | |
| Address | Indegene Limited Aspen Block G4, 3rd Floor, Manyata Embassy Business Park, Outer Ring Road, Nagawara, Bengaluru 560 045, Karnataka |
| Phone: | +91 80 4674 4567 |
| compliance.officer@indegene.com | |
| Website | www.indegene.com |
| Indegene Limited IPO Lead Managers |
| Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited J.P. Morgan India Private Limited Nomura Financial Advisory and Securities (India) Private Limited |
| Indegene Limited IPO Registrar | |
| . | Link Intime India Private Ltd |
| Phone | +91 810 811 4949 |
| jnkindia.ipo@linkintime.co.in | |
| Website | https://linkintime.co.in/ |
| Indegene Limited IPO Allotment Status Check |
| IPO Allotment Status Check Click Here |
Indegene Limited IPO FAQs
What is Indegene Limited IPO?
- Indegene Limited IPO is a MAIN BOARD IPO. They are going to raise ₹1,841.76 Crores via IPO. The issue is priced at ₹430 to ₹452 per equity share. The IPO is to be listed on NSE, BSE
When Indegene Limited IPO will open?
- The IPO is to open on May 06, 2024, for QIB, NII, and Retail Investors.
What is Indegene Limited IPO Investors Portion?
- The investors’ portion for QIB is 50%, NII is 15%, and Retail is 35%.
What is Indegene Limited IPO Size?
- Indegene Limited IPO size is ₹1,841.76 crores.
What is Indegene Limited IPO Price Band?
- Indegene Limited IPO Price Band is ₹430 To ₹452 per equity share.
What is Indegene Limited IPO Minimum and Maximum Lot Size?
- The IPO bid is Minimum 1-Lot (33 Shares) with ₹14,916 and Maximum Lot Size 13-Lots (429 Shares) with ₹193,908
What is Indegene Limited IPO Allotment Date?
- Indegene Limited IPO allotment date is May 09, 2024.
What is Indegene Limited IPO Listing Date?
- Indegene Limited IPO listing date is May 13, 2024. The IPO to list on NSE, BSE.